工程NiFe2O4与IrO2装饰在血处理的铁泡上,用于增强电催化进化
Tao Sun1, Bin He1, Guoxiang Pan1
1Zhejiang Key Laboratory for Industrial Solid Waste Thermal Hydrolysis Technology and Intelligent Equipment, Huzhou Key Laboratory of Environmental Functional Materials and Pollution Control, Department of Materials Engineering, Huzhou University, Huzhou 313000, China.
Journal of colloid and interface science
|May 15, 2025
概括
研究人员开发了一种新的等离子体辅助方法,用于制造高效的氧化-氧化铁-氧化电催化剂,用于演化反应 (HER). 这种持久的催化剂表现出卓越的性能和稳定性,推进了HER技术.
科学领域:
- 材料科学 材料科学 材料科学
- 电化学 电化学 电化学
- 血科学是一门科学课.
背景情况:
- 为演化反应 (HER) 开发高效的电催化剂对于推进清洁能源技术至关重要.
- 当前的HER系统面临着与效率,耐用性和成本相关的挑战.
研究的目的:
- 使用等离子体辅助策略设计一种新的异构结构电催化剂.
- 为 HER.解决现有电催化剂的局限性.
- 调查开发的催化剂的性能和稳定性.
主要方法:
- 在使用介电屏障放电 (DBD) 等离子体的等离子体改性铁泡 (PFF) 上制造NiFe2O4-IrO2异构电催化剂.
- 催化剂的结构和电化学性质的表征.
- 密度函数理论 (DFT) 计算以了解协同效应.
主要成果:
- 经过等离子处理的PFF基板呈现出3D层次结构,增强的界面结合,以及改进的气体演变动力学.
- 优化的NiFe2O4-IrO2/PFF催化剂显示了HER的超低超电位 (24mV在10 mA cm-2).
- 催化剂保持了出色的稳定性,在10 mA cm-2.2下保持了100小时以上的活性.
- DFT计算证实了NiFe2O4和IrO2之间的协同效应,有助于高性能.
结论:
- 等离子体辅助制造策略是有效的,用于创建高度活跃和耐用的HER电催化剂.
- NiFe2O4-IrO2/PFF催化剂代表了生产技术的有希望的进步.
- 这种方法为开发下一代电催化系统提供了可行的途径.
相关概念视频
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
409
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
409
Antianginal Drugs: Nitrates and β-Blockers
459
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
459
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
719
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
719
Drug Delivery: Enteral Route
350
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
350
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Antihypertensive Drugs: Action of Calcium Channel Blockers
396
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
396


